---
title: "Valiant Laboratories Ltd (VALIANTLAB) — Share Price, Financials & Analysis"
symbol: "VALIANTLAB"
company: "Valiant Laboratories Ltd"
canonical: "https://tapetide.com/stocks/VALIANTLAB"
isin: "INE0JWS01017"
nse_symbol: "VALIANTLAB"
bse_code: "543998"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 643.93
generated_at: "2026-09-13T18:19:20.007Z"
---

# Valiant Laboratories Ltd (VALIANTLAB)

Canonical page: https://tapetide.com/stocks/VALIANTLAB

## Company

- **NSE Symbol:** VALIANTLAB
- **BSE Code:** 543998
- **ISIN:** INE0JWS01017
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-10-06
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** valiantlabs.in

## About

Incorporated in 1980, Valiant Laboratories 
Ltd manufactures and deals in Pharmaceuticals and speciality chemicals[1]

## Latest Price

- **Price:** ₹127.91
- **Change:** +3.11 (+2.49%)
- **Open:** ₹118.56
- **Day High:** ₹129.9
- **Day Low:** ₹118.56
- **Previous Close:** ₹124.8
- **Volume:** 234978
- **As Of:** 2026-09-11T10:21:10+00:00

## Key Fundamentals

Observed at 2026-09-11T04:41:52.625027Z.

- **Market Cap:** ₹643.93 Cr
- **Classification:** Microcap
- **P/E (reported):** 42.3
- **P/E (TTM):** 43.51
- **EPS (TTM):** ₹2.94
- **Book Value:** ₹57.24
- **Price to Book:** 2.18
- **Dividend Yield:** 0%
- **ROE:** -0.94%
- **ROCE:** -0.39%
- **Debt to Equity:** 0.15
- **Revenue (yearly):** ₹237.47 Cr
- **Net Income:** ₹-0.87 Cr
- **EBITDA:** ₹6.39 Cr
- **52-Week High:** ₹125.82
- **52-Week Low:** ₹49.51
- **RSI (14):** 80.68

## Tapetide Score

- **Score:** 43 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 22.3 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 50.73 | 9% |
| growth | 98.9 | 9% |
| momentum | 94.28 | 12% |
| ownership | 37.84 | 24% |
| quality | 19.25 | 22% |
| valuation | 42.49 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is expected to give good quarter

### Weaknesses

- Company has a low return on equity of -1.41% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -30.69% | -97.66% | 298.48% |
| ebitda margin growth | 502% | 392.59% | 303.03% | — |
| net income growth | — | -60.45% | -390% | — |
| revenue growth | 26.03% | 71.09% | -11% | — |
| roce | — | 77.27% | -101.65% | — |
| roe | — | -823.08% | 9.35% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 60 | 41 | 31 | 19 | 21 | 35 | 58 | 47 | 46 | 52 | 92 | 115 |
| Expenses | 61 | 47 | 35 | 21 | 28 | 35 | 54 | 44 | 46 | 53 | 87 | 86 |
| Operating Profit | -1 | -6 | -5 | -2 | -7 | 1 | 4 | 2 | 0 | -1 | 5 | 29 |
| OPM % | -2.3 | -16 | -15 | -13 | -31 | 1.8 | 7 | 5 | 0.2 | -1.7 | 5 | 25 |
| Other Income | 3 | 2 | 2 | 3 | 3 | 2 | -2 | 1 | 1 | 1 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Profit before tax | 1 | -5 | -3 | 0 | -4 | 2 | 1 | 2 | 0 | -3 | 1 | 26 |
| Tax % | 25 | -31 | -52 | 219 | 21 | -44 | 26 | 26 | 25 | 136 | -68 | 19 |
| Net Profit | 1 | -4 | -1 | -1 | -5 | 2 | 1 | 2 | 0 | -7 | 2 | 21 |
| EPS in Rs | 0.19 | -0.64 | -0.23 | -0.09 | -0.87 | 0.43 | 0.13 | 0.34 | 0.04 | -1.3 | 0.32 | 3.88 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- |
| Sales | 334 | 182 | 133 | 237 | 306 |
| Expenses | 299 | 190 | 138 | 231 | 273 |
| Operating Profit | 35 | -8 | -5 | 6 | 33 |
| OPM % | 11 | -4.6 | -3.5 | 2.7 | 11 |
| Other Income | 5 | 10 | 5 | 2 | 3 |
| Interest | 0 | 0 | 0 | 2 | 3 |
| Depreciation | 2 | 2 | 2 | 6 | 8 |
| Profit before tax | 38 | -1 | -2 | 1 | 25 |
| Tax % | 24 | -142 | 46 | 525 | — |
| Net Profit | 29 | 0 | -2 | -3 | 16 |
| EPS in Rs | 7.13 | 0.06 | -0.41 | -0.6 | 2.94 |
| Dividend Payout % | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 33 | 43 | 43 | 54 |
| Reserves | 68 | 193 | 191 | 257 |
| Borrowings | 60 | 77 | 122 | 46 |
| Other Liabilities | 52 | 29 | 45 | 107 |
| Total Liabilities | 213 | 343 | 401 | 464 |
| Fixed Assets | 48 | 50 | 48 | 227 |
| CWIP | 1 | 43 | 156 | 6 |
| Investments | 34 | 38 | 0 | 28 |
| Other Assets | 130 | 212 | 197 | 202 |
| Total Assets | 213 | 343 | 401 | 464 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 56 | 2 | 1 | -10 |
| Cash from Investing Activity | -55 | -144 | -53 | 7 |
| Cash from Financing Activity | -1 | 152 | 45 | 2 |
| Net Cash Flow | 0 | 10 | -7 | -1 |
| Free Cash Flow | 18 | -44 | -112 | -45 |
| CFO/OP | 185 | -11 | 25 | -147 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 97 | 92 | 197 | 144 |
| Inventory Days | 17 | 22 | 13 | 84 |
| Days Payable | 62 | 56 | 128 | 174 |
| Cash Conversion Cycle | 52 | 57 | 82 | 54 |
| Working Capital Days | 70 | 106 | 156 | 156 |
| ROCE % | — | -2 | -1 | 1 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| FIIs | 8.64% | 7.08% | 3.48% | 1.89% | 0% | 0% | 0.64% | 0.63% | 0.02% | 0.01% | 0.2% | 0% |
| DIIs | 3.89% | 0.02% | 0.03% | 0% | 0% | 0% | 0% | 0.46% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 12.49% | 13.36% | 15.16% | 16.09% | 17.3% | 17.55% | 16.28% | 17.05% | 18.19% | 18.51% | 18.53% | 18.91% |
| Others | 0.04% | 4.6% | 6.39% | 7.07% | 7.76% | 7.51% | 8.13% | 6.92% | 6.85% | 6.55% | 6.33% | 6.15% |
| No. of Shareholders | 37434 | 15821 | 14914 | 14249 | 15189 | 15692 | 15036 | 14432 | 15075 | 14910 | 14657 | 14341 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 108.63 | Buy |
| EMA (10) | 112.68 | Buy |
| SMA (20) | 103.07 | Buy |
| EMA (20) | 103.05 | Buy |
| SMA (50) | 80.02 | Buy |
| EMA (50) | 88.01 | Buy |
| SMA (100) | 76.79 | Buy |
| EMA (100) | 79.5 | Buy |
| SMA (200) | 69.56 | Buy |
| EMA (200) | 76.38 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 81.87 | Sell |
| MACD (12,26,9) | 11.77 | Buy |
| Stochastic (14,3,3) | 97.28 | Sell |
| ADX (14) | 58.1 | Buy |
| Williams %R (14) | -5.19 | Sell |
| ATR (14) | 5.95 | High Volatility |
| ROC (12) | 18.58 | Buy |
| Stoch RSI (14) | 67.65 | Neutral |
| UO (7,14,28) | 79.44 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00700ecd-5633-44a6-8fa1-db594435a647.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd291da2-287a-4560-9558-e50f063e6528.pdf) |
| 2026-09-03 | [Notice Of 5Th Annual General Meeting And Annual Report For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb0407e-80a6-471c-8c6c-0291b5646292.pdf) |
| 2026-09-03 | [Letter To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=868ed8a8-7405-424b-8172-f439687a436d.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba23aaf9-ba4b-4e8f-9499-9f3d8cfa0cf7.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d369b3fd-ffa5-46ef-b00c-d495142361e3.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16259470-72ac-4645-b0d0-b52b7747ae67.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bae04387-f1da-4ab0-8d86-18d0fa06549c.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=934bda94-629a-4228-87af-1b3fd682d5a9.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb94a18d-1667-4a26-aaff-e898ea3d6af8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [For Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d45336d-a856-459b-9ded-2ca9e558c803.pdf) |
| 2026-05-14 | [Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53eb7b84-bfde-4aed-94ed-f0c74a91aa97.pdf) |
| 2026-05-14 | [Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9222c526-3f4e-463d-bf60-a34c9419411e.pdf) |
| 2026-02-11 | [Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6946727-82ce-4378-b1a8-367390c76370.pdf) |
| 2025-11-11 | [Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c492bcbc-fac0-4eb3-9586-d510a9907b2b.pdf) |
| 2025-08-08 | [Outcome Of Board Meeting Dated August 08 2025-Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10b3da6c-1be7-4a35-bc10-b63c3a9a727f.pdf) |
| 2025-05-20 | [Financial Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e5c164d-cea2-4e40-83d5-52547d8912f1.pdf) |
| 2025-02-07 | [Financial Results For The Quarter Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70f2b243-75e0-42d8-a31f-f42e25f02351.pdf) |
| 2024-11-12 | [Financial Results For The Quarter Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25eb6c6a-66b7-4b8b-9d54-c0ef4991fb82.pdf) |
| 2024-08-12 | [Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c984c32-b2c7-4d6a-aa3c-455764c3ab3d.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - Board meeting on Feb 11, 2026 to approve standalone/consolidated audited results for quarter and nine months ended Dec 31, 2025. | [Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended December 31, 2025. 6 Feb - Board meeting on Feb 11, 2026 to approve standalone/consolidated audited results for quarter and nine months ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18449793-6837-4d25-b4e5-6d7585e4f4e4.pdf) |
| 23 Apr - Q.C Manager Bhanudas D. Patil resigned effective April 22, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 23 Apr - Q.C Manager Bhanudas D. Patil resigned effective April 22, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44af047d-8dd2-43d9-9b6d-1b2f557b0ea5.pdf) |
| 13 Feb - Copy of Newspaper Publication of Financial Results for the Quarter and NIne Months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Feb - Copy of Newspaper Publication of Financial Results for the Quarter and NIne Months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d05d0f8e-011d-4f44-aac3-58807c7c392e.pdf) |
| 13 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; all securities held in demat form. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; all securities held in demat form.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c7b79a8-c3a7-4c45-85fb-3a5ddeedd300.pdf) |
| 12h - Q.C Manager Bhanudas D. Patil resigned effective April 22, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 12h - Q.C Manager Bhanudas D. Patil resigned effective April 22, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/44af047d-8dd2-43d9-9b6d-1b2f557b0ea5.pdf) |
| 11h - Board meeting on May 14, 2026 to approve audited Q4 and FY26 standalone and consolidated results. | [Board Meeting Intimation for Approval Of Financial Results For Quarter And Year Ended March 31, 2026 11h - Board meeting on May 14, 2026 to approve audited Q4 and FY26 standalone and consolidated results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4a9ca9b5-f8d8-4155-9af9-55c31d1e8aa8.pdf) |
| 11 Feb - India Ratings' MA report: INR 8,146.88 lakh rights issue proceeds utilized; no deviation, quarter ended Dec 31, 2025. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 11 Feb - India Ratings' MA report: INR 8,146.88 lakh rights issue proceeds utilized; no deviation, quarter ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d820867d-0cea-4c0c-ba61-c35918d6a0b5.pdf) |
| 11 Feb - Board approved audited standalone and consolidated results for quarter and nine months ended 31 Dec 2025. | [Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2025. 11 Feb - Board approved audited standalone and consolidated results for quarter and nine months ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ebe0721c-91ba-4c64-b373-2a3712c6c0ed.pdf) |
| 11 Feb - Audited standalone and consolidated results approved for quarter and nine months ended 31-Dec-2025. | [Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2025. 11 Feb - Audited standalone and consolidated results approved for quarter and nine months ended 31-Dec-2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6946727-82ce-4378-b1a8-367390c76370.pdf) |
| — | [Closure of Trading Window 26 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d9688895-aa6c-4b76-a185-b9da62b81149.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dad4dfa9-658b-4964-bd91-921b22d9c249.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b50a737b-15bb-407c-b7e8-382773330878.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:20.007Z.